{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:26:27Z","timestamp":1793489187889,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR202211020017"],"award-info":[{"award-number":["ZR202211020017"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.neurot.2024.e00342","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T14:12:22Z","timestamp":1710511942000},"page":"e00342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Application of targeted liposomes-based salvianolic acid A for the treatment of ischemic stroke"],"prefix":"10.1016","volume":"21","author":[{"given":"Ming-Yan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Fang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00342_bib1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.neurot.2024.e00342_bib2","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.biopha.2018.11.041","article-title":"Neuroprotective agents in acute ischemic stroke-A reality check","volume":"109","author":"Goenka","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neurot.2024.e00342_bib3","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.thromres.2010.04.006","article-title":"Antiplatelet and antithrombotic activities of salvianolic acid A","volume":"126","author":"Fan","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.neurot.2024.e00342_bib4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.intimp.2011.07.022","article-title":"Salvianolic acid A suppress lipopolysaccharide-induced NF-\u03baB signaling pathway by targeting IKK\u03b2","volume":"11","author":"Oh","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2024.e00342_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-2952(92)90271-J","article-title":"Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes","volume":"43","author":"Liu","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00342_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3892\/etm.2017.4619","article-title":"Salvianolic acid A protects against myocardial ischemia\/reperfusion injury by reducing platelet activation and inflammation","volume":"14","author":"Yuan","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.neurot.2024.e00342_bib7","doi-asserted-by":"crossref","first-page":"153569","DOI":"10.1016\/j.phymed.2021.153569","article-title":"Salvianolic acid A alleviated inflammatory response mediated by microglia through inhibiting the activation of TLR2\/4 in acute cerebral ischemia-reperfusion","volume":"87","author":"Ling","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neurot.2024.e00342_bib8","first-page":"1717","article-title":"Salvianolic acid A alleviate the brain damage in rats after cerebral ischemia-reperfusion through Nrf2\/HO-1 pathway","volume":"51","author":"Zhang","year":"2016","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.neurot.2024.e00342_bib9","first-page":"65","article-title":"Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice","volume":"110","author":"Du","year":"1997","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.neurot.2024.e00342_bib10","doi-asserted-by":"crossref","first-page":"105989","DOI":"10.1016\/j.phrs.2021.105989","article-title":"Salvianolic acid A relieves cognitive disorder after chronic cerebral ischemia: involvement of Drd2\/Cryab\/NF-\u03baB pathway","volume":"175","author":"Yang","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neurot.2024.e00342_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jep.2013.05.013","article-title":"Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality","volume":"148","author":"Sun","year":"2013","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.neurot.2024.e00342_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainresbull.2019.07.015","article-title":"Liposomes for drug delivery in stroke","volume":"152","author":"Bruch","year":"2019","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurot.2024.e00342_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.phrs.2019.04.023","article-title":"Neuroprotective effects of andrographolide derivative CX-10 in transient focal ischemia in rat: involvement of Nrf2\/AE and TLR\/NF-\u03baB signaling","volume":"144","author":"Yang","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neurot.2024.e00342_bib14","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1213\/01.ANE.0000132973.32387.8B","article-title":"Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine","volume":"99","author":"Yokoo","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurot.2024.e00342_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40259-018-0309-y","article-title":"Emerging technologies for delivery of biotherapeutics and gene therapy across the blood-brain barrier","volume":"32","author":"Stanimirovic","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.neurot.2024.e00342_bib16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.euroneuro.2014.01.020","article-title":"Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects","volume":"24","author":"Werner","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neurot.2024.e00342_bib17","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101644R","article-title":"Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics","volume":"36","author":"Alata","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.neurot.2024.e00342_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2018.02.015","article-title":"Immunoliposomes in clinical oncology: state of the art and future perspectives","volume":"275","author":"Merino","year":"2018","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.neurot.2024.e00342_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2016.04.046","article-title":"Neuroprotection against cerebral ischemia\/reperfusion injury by intravenous administration of liposomal fasudil","volume":"506","author":"Fukuta","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.neurot.2024.e00342_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clineuro.2009.04.001","article-title":"The complexity of neurobiological processes in acute ischemic stroke","volume":"111","author":"Brouns","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurot.2024.e00342_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.neurot.2024.e00342_bib22","first-page":"2006","article-title":"Modulators of microglia activation and polarization in ischemic stroke (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.neurot.2024.e00342_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","article-title":"Microglial and macrophage polarization\u2014new prospects for brain repair","volume":"11","author":"Hu","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurot.2024.e00342_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12975-019-00728-5","article-title":"The dynamics of microglial polarization reveal the resident neuroinflammatory responses after subarachnoid hemorrhage","volume":"11","author":"Zheng","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.neurot.2024.e00342_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40360-022-00622-1","article-title":"Non-clinical safety evaluation of salvianolic acid A: acute, 4-week intravenous toxicities and genotoxicity evaluations","volume":"23","author":"Yang","year":"2022","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792400028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792400028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:17:49Z","timestamp":1742318269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792400028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S187874792400028X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00342","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of targeted liposomes-based salvianolic acid A for the treatment of ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00342"}}